These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 8370446)
1. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Seeger W; Grube C; Günther A; Schmidt R Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446 [TBL] [Abstract][Full Text] [Related]
2. Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity. Seeger W; Grube C; Günther A Am J Respir Cell Mol Biol; 1993 Sep; 9(3):239-47. PubMed ID: 8398160 [TBL] [Abstract][Full Text] [Related]
3. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant. Seeger W; Thede C; Günther A; Grube C Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155 [TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Seeger W; Günther A; Thede C Am J Physiol; 1992 Mar; 262(3 Pt 1):L286-91. PubMed ID: 1550251 [TBL] [Abstract][Full Text] [Related]
5. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593 [TBL] [Abstract][Full Text] [Related]
6. Resistance of different surfactant preparations to inactivation by meconium. Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417 [TBL] [Abstract][Full Text] [Related]
7. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs. Wang Z; Chang Y; Schwan AL; Notter RH Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674 [TBL] [Abstract][Full Text] [Related]
8. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness]. Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392 [TBL] [Abstract][Full Text] [Related]
9. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Cockshutt AM; Absolom DR; Possmayer F Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895 [TBL] [Abstract][Full Text] [Related]
10. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles. Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425 [TBL] [Abstract][Full Text] [Related]
11. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials. Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793 [TBL] [Abstract][Full Text] [Related]